Interleukin 13 Monoclonal Antibodies

334 Interleukin 13 monoclonal antibodies from 21 antibody suppliers Click each Interleukin 13 monoclonal antibody that interests you to view the full Interleukin 13 monoclonal antibody datasheet.

Flow Cytometry - Use Filter to switch application

Supplier data
Bio-Rad (formerly AbD Serotec) MCA2791F

Interleukin 13 antibody, MCA2791F, Bio-Rad (formerly AbD Serotec) . Figure A. Unstimulated cells were stained with Alexa Fluor 700 conjugated Mouse anti Human CD3 (<a href="https://www.bio-rad-antibodies.com/product/partnumber/MCA463A700.html">MCA463A700</a>) and FITC conjugated anti Human IL-13 (<a href="https://www.bio-rad-antibodies.com/product/partnumber/MCA2791F.html">MCA2791F</a>). Figure B. Cells stimulated with Cell Stimulation Reagent containing Brefeldin A (<a href="https://www.bio-rad-antibodies.com/product/partnumber/BUF077A.html">BUF077A</a>) for 6

Mouse Mono [B-P6], 100 Test
Hu
FACS

Supplier data
R&D Systems IC2131P Interleukin 13 antibody, IC2131P, R&D Systems. Detection of IL-13 in NS0 Mouse Cell Line Transfected with Human IL-13 by Flow Cytometry.

Interleukin 13 antibody, IC2131P, R&D Systems. Detection of IL-13 in NS0 Mouse Cell Line Transfected with Human IL-13 by Flow Cytometry.

Mouse Mono [32007], 100 Test
Hu
FACS

Supplier data
BioLegend 501915 Interleukin 13 antibody, 501915, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti- human CD3 then intracellularly stained with IL-13 (Clone JES10-5A2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Interleukin 13 antibody, 501915, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti- human CD3 then intracellularly stained with IL-13 (Clone JES10-5A2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Rat Mono [JES10-5A2], 25 Test
Hu
FACS

Supplier data
BioLegend 501916 Interleukin 13 antibody, 501916, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti- human CD3 then intracellularly stained with IL-13 (Clone JES10-5A2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Interleukin 13 antibody, 501916, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti- human CD3 then intracellularly stained with IL-13 (Clone JES10-5A2) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).

Rat Mono [JES10-5A2], 100 Test
Hu
FACS

Supplier data
BioLegend 501913 Interleukin 13 antibody, 501913, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti-human CD3 then intracellularly stained with IL-13 (clone JES10-5A2) PE/Cy7 (top) or rat IgG1, κ PE/Cy7 isotype control (bottom).

Interleukin 13 antibody, 501913, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti-human CD3 then intracellularly stained with IL-13 (clone JES10-5A2) PE/Cy7 (top) or rat IgG1, κ PE/Cy7 isotype control (bottom).

Rat Mono [JES10-5A2], 25 Test
Hu
FACS

Supplier data
BioLegend 501914 Interleukin 13 antibody, 501914, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti-human CD3 then intracellularly stained with IL-13 (clone JES10-5A2) PE/Cy7 (top) or rat IgG1, κ PE/Cy7 isotype control (bottom).

Interleukin 13 antibody, 501914, BioLegend. TH2 polarized human peripheral blood lymphocytes were surface stained with PE anti-human CD3 then intracellularly stained with IL-13 (clone JES10-5A2) PE/Cy7 (top) or rat IgG1, κ PE/Cy7 isotype control (bottom).

Rat Mono [JES10-5A2], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies MA5-23725

Interleukin 13 antibody, MA5-23725, Invitrogen Antibodies. Flow cytometric analysis of recombinant Human IL-13 stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL-13 (10 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-13 Monoclonal Antibody (Product # MA5-23725). The ND50 is typically 0.15-0.75 µg/mL.

Mouse Mono [32116], 500 ug
Hu
ELISA, FACS, Neu

ELISA,

Interleukin 13 antibody, MA5-23725, Invitrogen Antibodies, Neutralising image

Neu

Supplier data
Invitrogen Antibodies AHC0132 Interleukin 13 antibody, AHC0132, Invitrogen Antibodies. Human IL-13 Antibody. Isolated human PBMCs were stimulated and stained with the rat anti-human IL-13 R-PE. Data obtained represent the gated lymphocyte population. The diagram shows stimulated lymphocytes stained with rat anti-human IL-13 R-PE.

Interleukin 13 antibody, AHC0132, Invitrogen Antibodies. Human IL-13 Antibody. Isolated human PBMCs were stimulated and stained with the rat anti-human IL-13 R-PE. Data obtained represent the gated lymphocyte population. The diagram shows stimulated lymphocytes stained with rat anti-human IL-13 R-PE.

Rat Mono [JES10-5A2], 500 ug
Hu
ELISA, FACS, IHC-P, Neu, WB

ELISA, IHC-P, Neu, WB

Supplier data
Invitrogen Antibodies 25-7133-82

Interleukin 13 antibody, 25-7133-82, Invitrogen Antibodies. CD4+ BALB/c splenocytes were stimulated for 10-days under Th2 polarizing conditions. Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours. Following restimulation, cells were fixed and permeabilized using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and then stained with Anti-Mouse CD4 eFluor® 450 (Product # 48-0042-82) and 0.25 µg of Rat IgG1 K Isotype Control PE-Cyanine7 (

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7136-41

Interleukin 13 antibody, 12-7136-41, Invitrogen Antibodies. Normal human peripheral blood cells were unstimulated (left) or stimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right). Cells were stained intracellularly with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-13 PE using the Intracellular Fixation and Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [85BRD], 25 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 50-7133-82

Interleukin 13 antibody, 50-7133-82, Invitrogen Antibodies. BALB/c splenocytes were polarized under Th2 conditions for 3 days and then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control eFluor® 660 (Product # 50-4301-82) (left) or 0.125 µg of Anti-Mouse IL-13 eFluor® 660 (right). Total viable cells, as determined

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 48-7133-80

Interleukin 13 antibody, 48-7133-80, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then stain

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7133-81

Interleukin 13 antibody, 12-7133-81, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained w

Rat Mono [eBio13A], 50 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 53-7133-80 Interleukin 13 antibody, 53-7133-80, Invitrogen Antibodies. Intracellular staining of Th2-polarized and restimulated CD4+ splenocytes with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4301-80) (left) or 0.125 µg of Anti-Mouse IL-13 Alexa Fluor® 488 (right).

Interleukin 13 antibody, 53-7133-80, Invitrogen Antibodies. Intracellular staining of Th2-polarized and restimulated CD4+ splenocytes with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4301-80) (left) or 0.125 µg of Anti-Mouse IL-13 Alexa Fluor® 488 (right).

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 47-7133-80

Interleukin 13 antibody, 47-7133-80, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-93) for 5 hours. Following restimulation, cells were fixed and perme

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 46-7133-82

Interleukin 13 antibody, 46-7133-82, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then stain

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 61-7133-80

Interleukin 13 antibody, 61-7133-80, Invitrogen Antibodies. CD4+ BALB/c splenocytes were stimulated for 6 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then either non-restimulated (left) or restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours (right). Foll

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 53-7133-82 Interleukin 13 antibody, 53-7133-82, Invitrogen Antibodies. Intracellular staining of Th2-polarized and restimulated CD4+ splenocytes with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4301-80) (left) or 0.125 µg of Anti-Mouse IL-13 Alexa Fluor® 488 (right).

Interleukin 13 antibody, 53-7133-82, Invitrogen Antibodies. Intracellular staining of Th2-polarized and restimulated CD4+ splenocytes with Anti-Mouse CD4 PerCP-eFluor® 710 (Product # 46-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control Alexa Fluor® 488 (Product # 53-4301-80) (left) or 0.125 µg of Anti-Mouse IL-13 Alexa Fluor® 488 (right).

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 25-7133-80

Interleukin 13 antibody, 25-7133-80, Invitrogen Antibodies. CD4+ BALB/c splenocytes were stimulated for 10-days under Th2 polarizing conditions. Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours. Following restimulation, cells were fixed and permeabilized using the Intracellular Fixation & Permeabilization Buffer Set (Product # 88-8824-00) and then stained with Anti-Mouse CD4 eFluor® 450 (Product # 48-0042-82) and 0.25 µg of Rat IgG1 K Isotype Control PE-Cyanine7 (

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 46-7133-80

Interleukin 13 antibody, 46-7133-80, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then stain

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 48-7133-82

Interleukin 13 antibody, 48-7133-82, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then stain

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7133-82

Interleukin 13 antibody, 12-7133-82, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized then stained w

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 12-7136-42

Interleukin 13 antibody, 12-7136-42, Invitrogen Antibodies. Normal human peripheral blood cells were unstimulated (left) or stimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right). Cells were stained intracellularly with Anti-Human CD4 APC (Product # 17-0049-42) and Anti-Human IL-13 PE using the Intracellular Fixation and Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [85BRD], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 61-7133-82

Interleukin 13 antibody, 61-7133-82, Invitrogen Antibodies. CD4+ BALB/c splenocytes were stimulated for 6 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then either non-restimulated (left) or restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) for 5 hours (right). Foll

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 11-7136-42

Interleukin 13 antibody, 11-7136-42, Invitrogen Antibodies. Normal human peripheral blood cells were unstimulated (left) or stimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right). Cells were stained intracellularly with Anti-Human CD4 PE (Product # 12-0049-42) and Anti-Human IL-13 FITC using the Intracellular Fixation and Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [85BRD], 100 Test
Hu
FACS

Supplier data
Invitrogen Antibodies 47-7133-82

Interleukin 13 antibody, 47-7133-82, Invitrogen Antibodies. BALB/c splenocytes were stimulated for 3 days with plate-bound Anti-Mouse CD3e Functional Grade Purified (Product # 16-0031-82), soluble Anti-Mouse CD28 Functional Grade Purified (Product # 16-0281-82), Mouse IL-2 Recombinant Protein (Product # 14-8021-64), and Mouse IL-4 Recombinant Protein (Product # 14-8041-80). Cells were then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-93) for 5 hours. Following restimulation, cells were fixed and perme

Rat Mono [eBio13A], 100 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 50-7133-80

Interleukin 13 antibody, 50-7133-80, Invitrogen Antibodies. BALB/c splenocytes were polarized under Th2 conditions for 3 days and then restimulated with Cell Stimulation Cocktail (plus protein transport inhibitors) for 5 hours. Following restimulation, cells were fixed and permeabilized and then intracellularly stained with Anti-Mouse CD4 FITC (Product # 11-0042-82) and 0.125 µg of Rat IgG1 K Isotype Control eFluor® 660 (Product # 50-4301-82) (left) or 0.125 µg of Anti-Mouse IL-13 eFluor® 660 (right). Total viable cells, as determined

Rat Mono [eBio13A], 25 ug
Mo
FACS

Supplier data
Invitrogen Antibodies 11-7136-41

Interleukin 13 antibody, 11-7136-41, Invitrogen Antibodies. Normal human peripheral blood cells were unstimulated (left) or stimulated for 5 hours with the Cell Stimulation Cocktail (plus protein transport inhibitors) (Product # 00-4975-03) (right). Cells were stained intracellularly with Anti-Human CD4 PE (Product # 12-0049-42) and Anti-Human IL-13 FITC using the Intracellular Fixation and Permeabilization Buffer Set (Product # 88-8824-00) and protocol. Cells in the lymphocyte gate were used for analysis.

Mouse Mono [85BRD], 25 Test
Hu
FACS

Enzyme Linked Immunosorbent Assay

Supplier data
BioLegend 501901 Interleukin 13 antibody, 501901, BioLegend.

Rat Mono [JES10-5A2], 50 ug
Hu
ELISA, IHC-F, IHC-P, WB

IHC-F, IHC-P, WB

Supplier data
BioLegend 501902 Interleukin 13 antibody, 501902, BioLegend.

Rat Mono [JES10-5A2], 500 ug
Hu
ELISA, IHC-F, IHC-P, WB

IHC-F, IHC-P, WB

Supplier data
Invitrogen Antibodies 14-7139-81 Interleukin 13 antibody, 14-7139-81, Invitrogen Antibodies. Human PBMCs (300,000/well) in 100 µL complete RPMI medium were treated without (left) or with (right) Candida (100 µg/mL) for 24 hrs in an IL-13 ELISPOT assay.

Interleukin 13 antibody, 14-7139-81, Invitrogen Antibodies. Human PBMCs (300,000/well) in 100 µL complete RPMI medium were treated without (left) or with (right) Candida (100 µg/mL) for 24 hrs in an IL-13 ELISPOT assay.

Mouse Mono [PVM13-1], 50 ug
Hu
ELISA, FA, FACS, Neu

FA, FACS, Neu

Supplier data
Invitrogen Antibodies 16-7135-81 Interleukin 13 antibody, 16-7135-81, Invitrogen Antibodies. Mouse IL-13 ELISPOT: Splenocytes were activated with immobilized Anti-Mouse CD3 (Product # 16-0031-82) and Anti-Mouse CD28 (Product # 16-0281-82) for 24 hrs in a Mouse IL-13 ELISPOT assay (right). Left well is medium alone control (no mitogen).

Interleukin 13 antibody, 16-7135-81, Invitrogen Antibodies. Mouse IL-13 ELISPOT: Splenocytes were activated with immobilized Anti-Mouse CD3 (Product # 16-0031-82) and Anti-Mouse CD28 (Product # 16-0281-82) for 24 hrs in a Mouse IL-13 ELISPOT assay (right). Left well is medium alone control (no mitogen).

Rat Mono [eBio1316H], 50 ug
Mo
ELISA, FA, Neu

FA, Neu

Supplier data
Invitrogen Antibodies 16-7135-85 Interleukin 13 antibody, 16-7135-85, Invitrogen Antibodies. Mouse IL-13 ELISPOT: Splenocytes were activated with immobilized Anti-Mouse CD3 (Product # 16-0031-82) and Anti-Mouse CD28 (Product # 16-0281-82) for 24 hrs in a Mouse IL-13 ELISPOT assay (right). Left well is medium alone control (no mitogen).

Interleukin 13 antibody, 16-7135-85, Invitrogen Antibodies. Mouse IL-13 ELISPOT: Splenocytes were activated with immobilized Anti-Mouse CD3 (Product # 16-0031-82) and Anti-Mouse CD28 (Product # 16-0281-82) for 24 hrs in a Mouse IL-13 ELISPOT assay (right). Left well is medium alone control (no mitogen).

Rat Mono [eBio1316H], 500 ug
Mo
ELISA, FA, Neu

FA, Neu

Supplier data
Invitrogen Antibodies 16-7139-81 Interleukin 13 antibody, 16-7139-81, Invitrogen Antibodies. Normal human peripheral blood cells (300,000/well) in 100 µl complete RPMI medium were treated without (left) or with (right) Candida (100 µg/mL) for 24 hrs in an IL-13 ELISPOT assay.

Interleukin 13 antibody, 16-7139-81, Invitrogen Antibodies. Normal human peripheral blood cells (300,000/well) in 100 µl complete RPMI medium were treated without (left) or with (right) Candida (100 µg/mL) for 24 hrs in an IL-13 ELISPOT assay.

Mouse Mono [PVM13-1], 50 ug
Hu
ELISA, FA, Neu

FA, Neu

Supplier data
ProSci 51-289 Interleukin 13 antibody, 51-289, ProSci. Immunohistochemistry of rat spleen tissue stained using IL-13 Monoclonal Antibody.

Interleukin 13 antibody, 51-289, ProSci. Immunohistochemistry of rat spleen tissue stained using IL-13 Monoclonal Antibody.

Mouse Mono [[A130D 12G5 1E4]], 125 ug
Rt
ELISA, FACS, IHC-F, IHC-P, WB

FACS,

Interleukin 13 antibody, 51-289, ProSci, Immunohistochemistry frozen image

IHC-F,

Interleukin 13 antibody, 51-289, ProSci, Immunohistochemistry paraffin image

IHC-P, WB

Supplier data
GeneTex GTX02960 Interleukin 13 antibody, GTX02960, GeneTex. Sandwich ELISA analysis of monkey IL-13 protein using GTX02960 IL13 antibody [IL13-I] as coating antibody and GTX02959-02 IL13 antibody [IL13-3] (Biotin) as detecting antibody.<br>Substrate : pNPP

Interleukin 13 antibody, GTX02960, GeneTex. Sandwich ELISA analysis of monkey IL-13 protein using GTX02960 IL13 antibody [IL13-I] as coating antibody and GTX02959-02 IL13 antibody [IL13-3] (Biotin) as detecting antibody.<br>Substrate : pNPP

Mouse Mono [IL13-I], 250 ug
Hu, Pr
ELISA

Supplier data
GeneTex GTX02959-02 Interleukin 13 antibody, GTX02959-02, GeneTex. Sandwich ELISA analysis of monkey IL-13 protein using GTX02960 IL13 antibody [IL13-I] as coating antibody and GTX02959-02 IL13 antibody [IL13-3] (Biotin) as detecting antibody.<br>Substrate : pNPP

Interleukin 13 antibody, GTX02959-02, GeneTex. Sandwich ELISA analysis of monkey IL-13 protein using GTX02960 IL13 antibody [IL13-I] as coating antibody and GTX02959-02 IL13 antibody [IL13-3] (Biotin) as detecting antibody.<br>Substrate : pNPP

Rat Mono [IL13-3], 250 ug
Hu, Pr
ELISA

Supplier data
GeneTex GTX02958 Interleukin 13 antibody, GTX02958, GeneTex. Sandwich ELISA analysis of human IL-13 protein using GTX02958 IL13 antibody [25K2] as coating antibody and GTX02961-02 IL13 antibody [MT1318] (Biotin) as detecting antibody.<br>Substrate : pNPP

Interleukin 13 antibody, GTX02958, GeneTex. Sandwich ELISA analysis of human IL-13 protein using GTX02958 IL13 antibody [25K2] as coating antibody and GTX02961-02 IL13 antibody [MT1318] (Biotin) as detecting antibody.<br>Substrate : pNPP

Rat Mono [25K2], 250 ug
Hu
ELISA

Supplier data
GeneTex GTX02961-02 Interleukin 13 antibody, GTX02961-02, GeneTex. Sandwich ELISA analysis of human IL-13 protein using GTX02958 IL13 antibody [25K2] as coating antibody and GTX02961-02 IL13 antibody [MT1318] (Biotin) as detecting antibody.<br>Substrate : pNPP

Interleukin 13 antibody, GTX02961-02, GeneTex. Sandwich ELISA analysis of human IL-13 protein using GTX02958 IL13 antibody [25K2] as coating antibody and GTX02961-02 IL13 antibody [MT1318] (Biotin) as detecting antibody.<br>Substrate : pNPP

Mouse Mono [MT1318], 250 ug
Hu
ELISA

Western Blot

Supplier data
Boster Biological Technology M00077 Interleukin 13 antibody, M00077, Boster Biological Technology. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL13 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IL13.

Interleukin 13 antibody, M00077, Boster Biological Technology. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL13 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IL13.

Mouse Mono [OTI6D3], 100 ul
Hu
WB

Supplier data
Origene TA804004S Interleukin 13 antibody, TA804004S, Origene.

Mouse Mono [OTI4G5], 30 ul
Hu
WB

Supplier data
Origene CF804004 Interleukin 13 antibody, CF804004, Origene.

Mouse Mono [Clone OTI6D3], 100 ug
Hu
WB

Supplier data
Origene TA804004 Interleukin 13 antibody, TA804004, Origene.

Mouse Mono [Clone OTI6D3], 100 ul
Hu
WB

Interleukin 13 antibodies are often published with	Associated citations
IL-4	25.3%
IL-17	7.3%
ATP Binding Cassette Subfamily G Member 2 (Junior Blood Group)	6.2%
IL-12	5.6%
Interleukin 10	3.5%
c-Kit	2.8%
CD1d Molecule	2.4%
Mouse IgE	2.4%
PMP-22	2.4%
CD19	2.4%

Bac	Bacteria
Bt	Bat
Bv	Bovine
Cel	C.Elegans
Cml	Camel
Cn	Canine
chem	Chemical
Ch	Chicken
Dk	Donkey
Dr	Drosophila
Du	Duck
Eq	Equine
Eu	Eukaryotes
Fe	Feline
Fi	Fish
Fr	Frog
Fu	Fungus
Gt	Goat
Gf	Goldfish
GP	Guinea Pig
Ha	Hamster
Hu	Human
Inv	Invertebrates
Llm	Llama
Mam	Mammals
Mo	Mouse
Pl	Plant
Po	Porcine
Pr	Primate
Pro	Prokaryotes
Rb	Rabbit
Rt	Rat
Sh	Sheep
Sq	Squirrel
Vert	Vertebrates
Vi	Virus
Xe	Xenopus
Yt	Yeast
Zf	Zebrafish

AP	Affinity purification
Bl	Blocking
ChIP	Chromatin Immunoprecipitation
DB	Dot Blot
EMSA	Electron Microscopy
ELISA	Enzyme Linked Immunosorbent Assay
FACS	Flow Cytometry
FA	Functional Assay
GS	Gel Shift
ICC	Immunocytochemistry
ID	Immunodiffusion
IF	Immunofluorescence
IHC-F	Immunohistochemistry frozen
IHC-P	Immunohistochemistry paraffin
IP	Immunoprecipitation
IVT	In vivo targeting
Neu	Neutralising
Pep-ELISA	Peptide ELISA
PLA	Proximity Ligation Assay
RIA	Radioimmunoassay
WB	Western Blot

334 matching Interleukin 13 monoclonal antibodies from 21 suppliers

Superstar Kits

Interleukin 13 information

Aliases

15 Applications, 5 Species currently selected